Neogenomics (NEO) Notes Payables (2024 - 2025)

Neogenomics (NEO) posted Notes Payables of $201.1 million for Q1 2025, little changed quarter-over-quarter from $200.8 million in Q4 2024.

Neogenomics (NEO) Notes Payables (2024 - 2025) Analysis & Trends

Neogenomics (NEO) has reported Notes Payables for 2 consecutive years, with $201.1 million the latest figure, recorded in Q1 2025.

Notes Payables for Q1 2025 came in at $201.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $201.1 million (changed N/A YoY), and the FY2024 annual result was $200.8 million, changed N/A from the prior year.
Notes Payables was $201.1 million for Q1 2025 at Neogenomics, roughly flat from $200.8 million in the prior quarter.
Over five years, Notes Payables peaked at $201.1 million in Q1 2025 and troughed at $200.1 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Neogenomics	1.93 Bn	1.79 Bn	80.86 Mn

Download Data